Triangle and Dynavax in viral deal

VIRS licensed from Dynavax (Berkeley, Calif.) exclusive global rights to immunostimulatory DNA sequences to treat HIV, and to treat or prevent hepatitis B, and hepatitis C viral infections. VIRS will ...